Contact
searchSearch
HMP Global

Advances in Nonmelanoma Skin Cancer

Vernon Sondak
Breakthroughs in Skin Cancer Care: Emerging Treatments
05/03/2025
Vernon Sondak, MD
Dr Sondak discusses the latest advancements in treating cutaneous squamous and basal cell cancers, including the role of immunotherapy, neoadjuvant treatments, and emerging strategies for high-risk patients.
Dr Sondak discusses the latest advancements in treating cutaneous squamous and basal cell cancers, including the role of immunotherapy, neoadjuvant treatments, and emerging strategies for high-risk patients.
Dr Sondak discusses the latest...
05/03/2025
The Dermatologist
Paul
Advancements in the Locoregional Treatment of Merkel Cell Carcinoma
04/01/2025
Paul Nghiem, MD, PhD
In this expert update, Dr Paul Nghiem shares advancements in local and regional management of Merkel cell carcinoma, emphasizing the importance of individualized treatment plans.
In this expert update, Dr Paul Nghiem shares advancements in local and regional management of Merkel cell carcinoma, emphasizing the importance of individualized treatment plans.
In this expert update, Dr Paul...
04/01/2025
The Dermatologist
Nour Kibbi
Rare Skin Tumors: An Evidence-Based Approach
03/15/2025
Nour Kibbi, MD, FAAD
Managing rare skin tumors requires a balance between institutional expertise and emerging evidence-based guidelines.
Managing rare skin tumors requires a balance between institutional expertise and emerging evidence-based guidelines.
Managing rare skin tumors...
03/15/2025
The Dermatologist
Vishal Patel
Advances in High-Risk Cutaneous Squamous Cell Carcinoma
02/28/2025
Riya Gandhi, MA
In this interview, Dr Vishal Patel discusses recent advances in high-risk cutaneous squamous cell carcinoma, focusing on gene expression profiling and promising treatment approaches.
In this interview, Dr Vishal Patel discusses recent advances in high-risk cutaneous squamous cell carcinoma, focusing on gene expression profiling and promising treatment approaches.
In this interview, Dr Vishal...
02/28/2025
The Dermatologist

Popular Articles

psoriatic arthritis
News
Assessing Areal Bone Mineral Density in Psoriatic Arthritis and Psoriasis
02/15/2024
Jessica Garlewicz
Researchers aimed to assess bone mineral density and bone quality in patients with psoriasis alone or with psoriatic arthritis compared to matched control subjects.
Researchers aimed to assess bone mineral density and bone quality in patients with psoriasis alone or with psoriatic arthritis compared to matched control subjects.
Researchers aimed to assess bone...
02/15/2024
The Dermatologist
Dr David Carr
Videos
Advancing a Mohs Surgery Leadership Program
04/03/2024
David R. Carr, MD, MPH, FACMS
In this interview, Dr Carr delves into the Mohs Surgeons Leading the Future project, discussing its objectives, specific projects, selection criteria, and outcomes. Discover how these initiatives contribute to the advancement of Mohs surgery...
In this interview, Dr Carr delves into the Mohs Surgeons Leading the Future project, discussing its objectives, specific projects, selection criteria, and outcomes. Discover how these initiatives contribute to the advancement of Mohs surgery...
In this interview, Dr Carr...
04/03/2024
The Dermatologist
Joel M. Gelfand, MD, MSCE
Conference Coverage
Hot Topics in Dermatology
05/08/2024
Jessica Garlewicz
The session aimed to delve into recent advancements in dermatology research, guided by Dr Gelfand, a leading figure in clinical dermatology research.
The session aimed to delve into recent advancements in dermatology research, guided by Dr Gelfand, a leading figure in clinical dermatology research.
The session aimed to delve into...
05/08/2024
The Dermatologist
Atopic dermatitis
News
Arcutis Presents Long-Term Data on Roflumilast Cream for Atopic Dermatitis
06/11/2024
Riya Gandhi, MA
At the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, Arcutis Biotherapeutics, Inc., unveiled new findings from the INTEGUMENT-OLE long-term open-label study of roflumilast cream 0.15% for adults and children with atopic...
At the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, Arcutis Biotherapeutics, Inc., unveiled new findings from the INTEGUMENT-OLE long-term open-label study of roflumilast cream 0.15% for adults and children with atopic...
At the Revolutionizing Alopecia...
06/11/2024
The Dermatologist
psoriatic arthritis
News
Vaccination Recommendations for Patients Receiving Antipsoriatic Systemic Therapies
07/26/2024
Jessica Garlewicz
Researchers aimed to evaluate the literature on vaccine efficacy and safety, using a modified Delphi process to generate 22 consensus-based recommendations for adults receiving systemic therapies for psoriasis.
Researchers aimed to evaluate the literature on vaccine efficacy and safety, using a modified Delphi process to generate 22 consensus-based recommendations for adults receiving systemic therapies for psoriasis.
Researchers aimed to evaluate...
07/26/2024
The Dermatologist

Subscribe

The Dermatologist Newsletter
New Issue - September 2025

Current Issue

September 2025
Volume 33
Issue 6
Current Issue
Issue Archive

Latest Quizzes and Trivia

acne
Quiz
Quiz: Pathophysiologic Pillars of Acne
09/25/2025
Jessica Garlewicz
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1...
09/25/2025
The Dermatologist
psoriasis
Quiz
Quiz: Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
09/25/2025
Jessica Garlewicz
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical...
09/25/2025
The Dermatologist
Quiz
When Should You Start a JAK Inhibitor for AA?
09/22/2025
Riya Gandhi, MA
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they...
09/22/2025
The Dermatologist
Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Quiz
How Long Before You Call a JAK Inhibitor Non-Responsive?
09/15/2025
Riya Gandhi, MA
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial...
09/15/2025
The Dermatologist
Quiz
What’s the Go-To Adjunct With JAKs in AA Regrowth?
09/08/2025
Riya Gandhi, MA
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but...
09/08/2025
The Dermatologist
psoriasis
Quiz
NPF Quiz: The Primary Goal of the S.T.R.A.N.D. Network
09/04/2025
Jessica Garlewicz
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals...
09/04/2025
The Dermatologist
Quiz
Ethical Arguments in AA: Cosmetic vs. Medical
08/21/2025
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in...
08/21/2025
The Dermatologist
psoriasis
Quiz
True or False: TYK2 Inhibition
08/14/2025
Jessica Garlewicz
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition...
08/14/2025
The Dermatologist
alopecia areata
Quiz
Alopecia Areata—JAK Inhibitor Indications
08/14/2025
Jessica Garlewicz
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients...
08/14/2025
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use